Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2023-05-04 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and circulars, and provides details of shareholders and share certificate numbers. The content is an official notification about share certificate issuance, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor is it a meeting material or voting result. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2023-05-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 28th April 2023 informing stock exchanges about an upcoming investor/analysts call on the financial results of Q1 for the financial year 2023. It provides details about the date, time, and registration link for the call. There is no actual financial data or report content included, only an announcement of the event. According to the classification rules, such a document announcing an investor call is best classified as a Call Transcript (CT) category, as it relates to a conference call event. However, since this is only an intimation of the call and not the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the call, not the transcript or the financial report itself. The document length is short (2069 characters), and it does not contain financial statements or detailed analysis, so it cannot be classified as an Interim Report (IR) or Earnings Release (ER). Therefore, the best fit is Regulatory Filings (RNS).
2023-04-28 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold an investor / analysts call ....
Regulatory Filings Classification · 95% confidence The document is a short notice dated 28th April 2023 informing stock exchanges about an upcoming investor/analysts call on the financial results of Q1 for the financial year 2023, scheduled for 11th May 2023. It provides details about the date, time, and registration link for the call. There is no actual financial data or report content included, only an announcement of the event. The document length is 2069 characters, which is short and consistent with an announcement rather than a full report or transcript. According to the rules, such announcements about upcoming calls are best classified as Regulatory Filings (RNS) because they do not contain the call transcript or financial results themselves, just the notice of the call.
2023-04-28 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and a SEBI circular. The content is about shareholder share certificate replacement and does not contain financial data, earnings, management discussion, or any report publication. It is a regulatory announcement related to share certificates and compliance, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-20 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share ....
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and provides details of shareholders and share certificate numbers. There is no financial data, earnings information, management discussion, or report attached or referenced. The document is a regulatory announcement about share certificate issuance, which does not fit into financial reports or meeting materials. It is not a report publication announcement since it contains substantive information about share certificates issued. The best fitting category is Regulatory Filings (RNS), as it is a compliance-related disclosure under SEBI regulations.
2023-04-20 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a notice dated 19th April 2023 from Sanofi India Limited regarding the publication of the Notice of the 67th Annual General Meeting (AGM) and e-voting information. It includes details about the AGM date (11th May 2023), the mode of the meeting (Video Conferencing/Other Audio-Visual Means), and instructions for shareholders on e-voting. The document also mentions that the Notice of the AGM, Directors' Report, Auditors' Report, and Audited Accounts for the year ended 31st December 2022 have been sent to members by email and are available on the company's website and stock exchange websites. The content is primarily about the announcement and logistics of the AGM and voting process, not the full AGM report or financial statements themselves. The document length is about 15,000 characters, but the content is focused on the notice and voting instructions rather than the full Annual Report or financial disclosures. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices related to it.
2023-04-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.